Welcome to Abdi Farma, a wholly owned subsidiary of Abdi Ibrahim Pharmaceuticals, the Turkish pharma industry leader with over 111 years of expertise, dedicated to providing high-quality healthcare products and services to customers around the world. Abdi Farma has marketing authorization for all Abdi Ibrahim products in European markets. With this strategy, Abdi Farma also licenses various products to international companies under exclusive supply agreements in its effort to strengthen its foothold in the international arena.
Abdi Farma started its journey through European markets in Portugal in 2010, then launching its first product under the Abdi Farma brand in 2013. Continuing its operations over the years via various stakeholders and business models, Abdi Farma’s business strategy evolved into a new form with the establishment of Abdi Farma Germany in 2022. Abdi Farma Germany is designed to serve European generics markets with high-quality medicine at affordable prices. Abdi Farma will continue to expand its reach across Europe, bringing its expertise in high-quality medicine to new customers.
Our commitment to quality, safety, compliance, and sustainability is evident in everything we do-- from research & development to manufacturing and distribution. With a diverse portfolio of products and a dedicated team of professionals, we are well-positioned to meet the evolving needs of the global pharmaceutical industry. We strive to create long-term value for our customers and shareholders, while also contributing to the well-being of society as a whole.
Thank you for visiting Abdi Farma's homepage. We invite you to learn more about our company and the many ways we are working to improve healthcare for people around the world.